FDA Adds Four Tropical Diseases to List Eligible for Priority Review Vouchers

Summary

The US Food and Drug Administration (FDA) has designated four new tropical diseases - chikungunya virus disease, Lassa fever, rabies, and cryptococcal meningitis - for priority review vouchers (PRVs) under the Federal Food, Drug, and Cosmetic Act. Eligible sponsors submitting applications for prevention or treatment of these diseases may be eligible to receive a PRV if approved by the FDA.